63 parallel-processing-bioinformatics-"SciLifeLab-" Postdoctoral positions at Yale University
Sort by
Refine Your Search
-
Show all breadcrumbs Postdoctoral Associate — Bioinformatics and Data Science — Stites Laboratory Monday, August 18, 2025 Postdoctoral Associate — Bioinformatics and Data Science — Stites Laboratory
-
Show all breadcrumbs Postgraduate Position in Computational Biology / Bioinformatics Yale School of Medicine / Yale Cancer Center Wednesday, February 11, 2026 Dr. Muneeb Alam and The Braun Lab (Yale
-
Show all breadcrumbs Postdoctoral Position in Bioinformatics — Barak and Gunel Laboratories — Department of Neurosurgery, Yale School of Medicine Wednesday, July 8, 2026 The Barak and Gunel
-
contribute to analyses and processing of data. They will become familiar with high performance computing environments and parallel processing, as well as cloud computing infrastructure. They will
-
biology, single-cell genomics, epigenetics, and bioinformatics. The typical term is 1 year, with extension to the second year if the student makes sufficient progress. The desired start date is June 1
-
and unstructured data in the electronic health record (EHR) as well as MyChart data, with the opportunity to work on applications of machine learning/deep learning/ Natural Language Processing in
-
(ASAP), NIH, and the endowed Yale Stephen & Denise Adams Center of Yale School of Medicine. Our lab is affiliated with the Yale Program in Computational Biology and Bioinformatics and the Departments of
-
development from virology, single-cell genomics, bioinformatics, immunology, to translational research. Our lab has a track record of training postdoctoral researchers: our postdocs have international
-
Description We are looking for strong, ambitious candidates with previous research backgrounds in molecular biology, human genetics, evolutionary biology, genomic technologies, bioinformatics, or machine
-
bioinformatics tools to understand the mechanisms driving malignant transformation through signaling pathways. Our lab recently showed that B-cell malignancies depend on efficient β-catenin